Tech Companies Put Billions Into Startups Aiming to Harvest the Blood of Children for Rejuvenation, Anti-Aging
Powerful tech corporations are putting billions of dollars into startups that intend to harvest the blood of children for the purposes of rejuvenation and anti-aging.
Newsweek published a profile on the growing industry, which includes injecting stem cells taken from dead mutilated fetuses into people, of humans playing God with disastrous consequences.
Stanford University neurologist Tony Wyss-Coray found years ago, with help from Saul Villeda, in 2011 and 2014 that injecting the blood of young mice into older mice had tremendously positive effects on their brain chemistry. His company Alkahest has done additional research in subsequent years.
Spanish firm Grifols has purchased Alkahest for $146 million, which may open up Pandora’s Box with regards to harvesting the blood of children. They hope to find a synthetic fountain of youth from researching the plasma of their young volunteers. This work is changing the field of geroscience forever, for better or worse.